AC
ALXN

Ascend Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Ascend Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
2017
Q3 		$5.5M Buy
2017
Q2 		– Sell
2017
Q1 		$15M Buy
2016
Q3 		– Sell
2016
Q2 		$24.4M Buy
2016
Q1 		– Sell
2015
Q4 		$2.22M Sell
2015
Q3 		$3.97M Sell
2015
Q2 		$30.9M Buy
2015
Q1 		$24.4M Buy